News
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...
The sale comes after a wave of customers and government officials demanded that 23andMe protect the genetic data it had built ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback